← Leaderboards
Robert H. Silverman
University Of Pennsylvania
$18,272,403
Attributed
$22,047,491
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$22,047,491 · 10
By mechanism
R01$19,142,019 · 5
M01$1,560,387 · 3
RC1$999,998 · 1
U54$345,087 · 1
Top collaborators
- Susan R. Weiss10 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Susan R. Weiss$24,407,392
- Francisco A Gonzalez-Scarano$10,891,253
Others in their field
Top investigators on “Interferons”
- Norman Wolmark · Nsabp Foundation, Inc.$62,740,119
- Kent J. Weinhold · Duke University$39,902,311
- Michael J Gale · University Of Texas Sw Med Ctr/Dallas$39,525,737
- Charles M. Rice · Rockefeller University$34,398,649
- Luis J. Montaner · Wistar Institute$32,339,250
- Lionel B Ivashkiv · Hospital For Special Surgery$29,564,114
Research focus
InterferonsAntiviral AgentsRibonucleasesCellsViralOligoadenylateVirusVirus DiseasesPathway InteractionsAntiviral ResponseVirus ReplicationCleaved CellSignal TransductionMediatingDouble-Stranded RnaLigaseIn VivoEnzymesGenesApoptosisLinkInhibitor/AntagonistLeadApoptotic
Grant awards (48)
Control of Viral Pathogenesis by Regulation of 2-5A Levels$788,579
R01 · FY2023 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$788,946
R01 · FY2022 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$794,957
R01 · FY2021 · AI
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L$402,500
R01 · FY2021 · AI · contact PI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$793,942
R01 · FY2020 · AI
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L$402,500
R01 · FY2020 · AI · contact PI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$823,351
R01 · FY2019 · AI
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L$400,625
R01 · FY2019 · AI · contact PI
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L$400,250
R01 · FY2018 · AI · contact PI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$713,295
R01 · FY2017 · AI
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L$415,250
R01 · FY2017 · AI · contact PI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$713,295
R01 · FY2016 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$713,295
R01 · FY2015 · AI
Antiviral Mechanisms of 2 5A Dependent RNASE L$373,495
R01 · FY2015 · CA · contact PI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$704,472
R01 · FY2014 · AI
Antiviral Mechanisms of 2 5A Dependent RNASE L$362,290
R01 · FY2014 · CA · contact PI
Control of Viral Pathogenesis by Regulation of 2-5A Levels$716,045
R01 · FY2013 · AI
Antiviral Mechanisms of 2 5A Dependent RNASE L$351,085
R01 · FY2013 · CA · contact PI
Antiviral Mechanisms of 2 5A Dependent RNASE L$373,495
R01 · FY2012 · CA · contact PI
Antiviral Mechanisms of 2 5A Dependent RNASE L$373,495
R01 · FY2011 · CA · contact PI
AMPLIFICATION OF ANTIVIRAL INNATE IMMUNITY BY SUPPRESSOR OF VIRUS RNA (svRNA)$499,999
RC1 · FY2010 · AI · contact PI
Antiviral Mechanisms of 2-5A Dependent RNase L$367,548
R01 · FY2010 · CA · contact PI
AMPLIFICATION OF ANTIVIRAL INNATE IMMUNITY BY SUPPRESSOR OF VIRUS RNA (svRNA)$499,999
RC1 · FY2009 · AI · contact PI
Antiviral Mechanisms of 2-5A Dependent RNase L$367,548
R01 · FY2009 · CA · contact PI
Antiviral Mechanisms of 2-5A Dependent RNase L$367,548
R01 · FY2008 · CA · contact PI
Broad Spectrum Antivirals Against Biodefense Select Agents That Activate RNase L$345,087
U54 · FY2008 · AI · contact PI
Role of RNase L in the Biology of Prostate Cancer$297,398
R01 · FY2008 · CA · contact PI
THE PREVALANCE OF DIABETES AMONG EMERGENCY DEPARTMENT PATIENTS WITH NO PREVIOUS$694,545
M01 · FY2007 · RR · contact PI
Antiviral Mechanisms of 2-5A Dependent RNase L$367,548
R01 · FY2007 · CA · contact PI
Role of RNase L in the Biology of Prostate Cancer$297,398
R01 · FY2007 · CA · contact PI
STRESS HYPERGLYCEMIA IN EMERGENCY DEPARTMENT (ED) PATIENTS: A NORMAL RESPONSE$697,190
M01 · FY2006 · RR · contact PI
Antiviral Mechanisms of 2 5A Dependent RNase L$399,866
R01 · FY2006 · CA · contact PI
Role of RNase L in the Biology of Prostate Cancer$306,280
R01 · FY2006 · CA · contact PI
Antiviral Mechanisms of 2-5A Dependent RNase L$252,349
R01 · FY2006 · CA · contact PI
Role of Phospholipid Scramblase in Interferon Action$409,006
R01 · FY2005 · CA
Antiviral Mechanisms of 2 5A Dependent RNase L$397,562
R01 · FY2005 · CA
Role of RNase L in the Biology of Prostate Cancer$313,650
R01 · FY2005 · CA
STRESS HYPERGLYCEMIA IN EMERGENCY DEPARTMENT (ED) PATIENTS: A NORMAL RESPONSE$168,652
M01 · FY2005 · RR
Role of Phospholipid Scramblase in Interferon Action$397,096
R01 · FY2004 · CA
Antiviral Mechanisms of 2 5A Dependent RNase L$385,983
R01 · FY2004 · CA
Role of RNase L in the Biology of Prostate Cancer$313,650
R01 · FY2004 · CA
Role of Phospholipid Scramblase in Interferon Action$398,782
R01 · FY2003 · CA
Antiviral Mechanisms of 2 5A Dependent RNase L$362,732
R01 · FY2003 · CA
Role of Phospholipid Scramblase in Interferon Action$368,424
R01 · FY2002 · CA
Antiviral Mechanisms of 2 5A Dependent RNase L$352,165
R01 · FY2002 · CA
Role of Phospholipid Scramblase in Interferon Action$346,461
R01 · FY2001 · CA
ANTIVIRAL MECHANISMS OF 2 5A DEPENDENT RNASE$337,705
R01 · FY2001 · CA
ANTIVIRAL MECHANISMS OF 2 5A DEPENDENT RNASE$330,158
R01 · FY2000 · CA